GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Itama Ranoraya Tbk (ISX:IRRA) » Definitions » Gross Profit

PT Itama Ranoraya Tbk (ISX:IRRA) Gross Profit : Rp88,663 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is PT Itama Ranoraya Tbk Gross Profit?

PT Itama Ranoraya Tbk's gross profit for the three months ended in Mar. 2024 was Rp27,573 Mil. PT Itama Ranoraya Tbk's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was Rp88,663 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. PT Itama Ranoraya Tbk's gross profit for the three months ended in Mar. 2024 was Rp27,573 Mil. PT Itama Ranoraya Tbk's Revenue for the three months ended in Mar. 2024 was Rp147,862 Mil. Therefore, PT Itama Ranoraya Tbk's Gross Margin % for the quarter that ended in Mar. 2024 was 18.65%.

PT Itama Ranoraya Tbk had a gross margin of 18.65% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

During the past 8 years, the highest Gross Margin % of PT Itama Ranoraya Tbk was 21.36%. The lowest was 16.47%. And the median was 20.91%.

Warning Sign:

PT Itama Ranoraya Tbk gross margin has been in long-term decline. The average rate of decline per year is -1.6%.


PT Itama Ranoraya Tbk Gross Profit Historical Data

The historical data trend for PT Itama Ranoraya Tbk's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Itama Ranoraya Tbk Gross Profit Chart

PT Itama Ranoraya Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 59,593.87 120,418.71 236,019.80 159,212.08 135,806.20

PT Itama Ranoraya Tbk Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54,932.13 20,839.49 - 61,090.01 27,572.53

Competitive Comparison of PT Itama Ranoraya Tbk's Gross Profit

For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Itama Ranoraya Tbk's Gross Profit Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's Gross Profit distribution charts can be found below:

* The bar in red indicates where PT Itama Ranoraya Tbk's Gross Profit falls into.



PT Itama Ranoraya Tbk Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

PT Itama Ranoraya Tbk's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=696303.792 - 560497.594
=135,806

PT Itama Ranoraya Tbk's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=147861.86 - 120289.333
=27,573

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp88,663 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

PT Itama Ranoraya Tbk's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=27,573 / 147861.86
=18.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PT Itama Ranoraya Tbk  (ISX:IRRA) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PT Itama Ranoraya Tbk had a gross margin of 18.65% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


PT Itama Ranoraya Tbk Gross Profit Related Terms

Thank you for viewing the detailed overview of PT Itama Ranoraya Tbk's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Itama Ranoraya Tbk (ISX:IRRA) Business Description

Traded in Other Exchanges
N/A
Address
MT. Haryono Square Lantai 1 Unit 101, Jl. Otto Iskandardinata Raya No. 390, No. 390 Jakarta Timur, Jakarta, IDN, 13330
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. The key revenue generating segments of the company are Sterile Non-Electromedical Medical Equipment and In Vitro Diagnostic product.

PT Itama Ranoraya Tbk (ISX:IRRA) Headlines

No Headlines